MKS (NASDAQ:MKSI) Given New $255.00 Price Target at Bank of America

MKS (NASDAQ:MKSI) had its target price lifted by investment analysts at Bank of America from $215.00 to $255.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the scientific and technical instruments company’s stock. Bank of America‘s target price would suggest a potential upside of 15.53% from the company’s previous close.

A number of other research firms have also recently commented on MKSI. Wall Street Zen cut shares of MKS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 3rd. Cantor Fitzgerald boosted their price target on shares of MKS from $200.00 to $300.00 and gave the company an “overweight” rating in a research note on Tuesday. The Goldman Sachs Group increased their price objective on shares of MKS from $92.00 to $125.00 and gave the stock a “sell” rating in a research report on Thursday, October 9th. Wells Fargo & Company boosted their target price on MKS from $150.00 to $175.00 and gave the company an “equal weight” rating in a research report on Thursday, January 15th. Finally, Needham & Company LLC upped their price target on MKS from $210.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday. Ten research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $208.42.

MKS Price Performance

NASDAQ:MKSI opened at $220.73 on Thursday. MKS has a one year low of $54.84 and a one year high of $221.07. The company has a debt-to-equity ratio of 1.64, a quick ratio of 1.81 and a current ratio of 2.86. The stock has a market cap of $14.83 billion, a PE ratio of 53.58, a P/E/G ratio of 1.94 and a beta of 1.92. The stock has a 50 day moving average price of $166.29 and a 200 day moving average price of $134.80.

MKS (NASDAQ:MKSI) last posted its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.13. MKS had a return on equity of 20.80% and a net margin of 7.25%.The company had revenue of $988.00 million for the quarter, compared to the consensus estimate of $963.87 million. During the same quarter in the previous year, the business earned $1.72 earnings per share. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Equities research analysts expect that MKS will post 6.94 EPS for the current fiscal year.

Insider Activity

In related news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total transaction of $47,643.00. Following the completion of the sale, the director owned 18,963 shares in the company, valued at $3,011,514.03. The trade was a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On MKS

A number of hedge funds and other institutional investors have recently made changes to their positions in MKSI. Greenleaf Trust increased its holdings in shares of MKS by 30.5% in the fourth quarter. Greenleaf Trust now owns 2,634 shares of the scientific and technical instruments company’s stock valued at $421,000 after purchasing an additional 615 shares during the period. Aaron Wealth Advisors LLC grew its position in MKS by 19.9% in the 4th quarter. Aaron Wealth Advisors LLC now owns 5,372 shares of the scientific and technical instruments company’s stock valued at $858,000 after buying an additional 892 shares during the last quarter. eCIO Inc. acquired a new position in MKS in the 4th quarter valued at $63,000. Earned Wealth Advisors LLC purchased a new position in MKS during the 4th quarter worth $204,000. Finally, Blue Trust Inc. lifted its position in MKS by 4.5% in the fourth quarter. Blue Trust Inc. now owns 4,227 shares of the scientific and technical instruments company’s stock valued at $675,000 after purchasing an additional 182 shares during the period. Hedge funds and other institutional investors own 99.79% of the company’s stock.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.